Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofía De la Villa

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Antimicrobial Agents|September 5, 2024
Effectiveness of short treatment duration for carbapenemase-producing Enterobacterales in bloodstream-infections: A retrospective cohort studySofía De la Villa, Celia Sánchez-Martínez, Emilia Cercenado, et al.
The Journal of Infectious Diseases|June 30, 2026
Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goalsClark D Russell, Sofía De La Villa, Maaike C Swets, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed?Lourdes Prats-Peinado, Tanya Fernández-Fernández, Miguel Márquez-Gómez, et al.
Journal of Medical Economics|March 23, 2023
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSISMaricela Valerio, Cristina Veintimilla, Carmen Rodríguez, et al.
Open Forum Infectious Diseases|February 13, 2023
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of <i>Clostridioides difficile</i> InfectionSofía de la Villa, Sergio Herrero, Patricia Muñoz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 27, 2025
Prospective analysis of biomarkers associated with successful faecal microbiota transplantation in recurrent Clostridioides difficile infectionSilvia Vázquez-Cuesta, María Olmedo, Martha Kestler, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 15, 2021
COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospitalRafael Ramos, Sofía de la Villa, Sergio García-Ramos, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 4, 2023
COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospitalRafael Ramos, Sofía de la Villa, Sergio García-Ramos, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2023
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)Sofía De La Villa, Carlos Sánchez-Carrillo, Celia Sánchez-Martínez, et al.
International Journal of Antimicrobial Agents|July 14, 2026
Rezafungin in the Management of Patients with Candida Osteoarticular Infections: Results from the REZ-GEIO projectSofía De La Villa, Jesús Guinea, Joan Gómez-Junyent, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Antimicrobial Agents|September 5, 2024
Effectiveness of short treatment duration for carbapenemase-producing Enterobacterales in bloodstream-infections: A retrospective cohort studySofía De la Villa, Celia Sánchez-Martínez, Emilia Cercenado, et al.
The Journal of Infectious Diseases|June 30, 2026
Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goalsClark D Russell, Sofía De La Villa, Maaike C Swets, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed?Lourdes Prats-Peinado, Tanya Fernández-Fernández, Miguel Márquez-Gómez, et al.
Journal of Medical Economics|March 23, 2023
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSISMaricela Valerio, Cristina Veintimilla, Carmen Rodríguez, et al.
Open Forum Infectious Diseases|February 13, 2023
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of <i>Clostridioides difficile</i> InfectionSofía de la Villa, Sergio Herrero, Patricia Muñoz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 27, 2025
Prospective analysis of biomarkers associated with successful faecal microbiota transplantation in recurrent Clostridioides difficile infectionSilvia Vázquez-Cuesta, María Olmedo, Martha Kestler, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 15, 2021
COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospitalRafael Ramos, Sofía de la Villa, Sergio García-Ramos, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 4, 2023
COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospitalRafael Ramos, Sofía de la Villa, Sergio García-Ramos, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2023
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)Sofía De La Villa, Carlos Sánchez-Carrillo, Celia Sánchez-Martínez, et al.
International Journal of Antimicrobial Agents|July 14, 2026
Rezafungin in the Management of Patients with Candida Osteoarticular Infections: Results from the REZ-GEIO projectSofía De La Villa, Jesús Guinea, Joan Gómez-Junyent, et al.
Pageof 3